Literature DB >> 24820695

More than 6 months of postoperative adjuvant chemotherapy results in loss of skeletal muscle: a challenge to the current standard of care.

Yasuhiro Kodera1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 24820695     DOI: 10.1007/s10120-014-0381-z

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


× No keyword cloud information.
  7 in total

Review 1.  Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms.

Authors:  E Gadéa; E Thivat; E Planchat; B Morio; X Durando
Journal:  Obes Rev       Date:  2011-12-01       Impact factor: 9.213

2.  Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer.

Authors:  Toru Aoyama; Takaki Yoshikawa; Junya Shirai; Tsutomu Hayashi; Takanobu Yamada; Kazuhito Tsuchida; Shinichi Hasegawa; Haruhiko Cho; Norio Yukawa; Takashi Oshima; Yasushi Rino; Munetaka Masuda; Akira Tsuburaya
Journal:  Ann Surg Oncol       Date:  2012-12-16       Impact factor: 5.344

3.  Skeletal muscle loss after total gastrectomy, exacerbated by adjuvant chemotherapy.

Authors:  Yusuke Yamaoka; Kazumasa Fujitani; Toshimasa Tsujinaka; Kazuyoshi Yamamoto; Motohiro Hirao; Mitsugu Sekimoto
Journal:  Gastric Cancer       Date:  2014-04-09       Impact factor: 7.370

Review 4.  Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress.

Authors:  Laura A A Gilliam; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2011-06-15       Impact factor: 8.401

5.  Nutritional recovery after open and laparoscopic gastrectomies.

Authors:  Shavkat Abdiev; Yasuhiro Kodera; Michitaka Fujiwara; Masahiko Koike; Goro Nakayama; Norifumi Ohashi; Chie Tanaka; Junichi Sakamoto; Akimasa Nakao
Journal:  Gastric Cancer       Date:  2011-02-16       Impact factor: 7.370

6.  Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial.

Authors:  Kerry S Courneya; Roanne J Segal; John R Mackey; Karen Gelmon; Robert D Reid; Christine M Friedenreich; Aliya B Ladha; Caroline Proulx; Jeffrey K H Vallance; Kirstin Lane; Yutaka Yasui; Donald C McKenzie
Journal:  J Clin Oncol       Date:  2007-09-04       Impact factor: 44.544

7.  Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.

Authors:  Shinichi Sakuramoto; Mitsuru Sasako; Toshiharu Yamaguchi; Taira Kinoshita; Masashi Fujii; Atsushi Nashimoto; Hiroshi Furukawa; Toshifusa Nakajima; Yasuo Ohashi; Hiroshi Imamura; Masayuki Higashino; Yoshitaka Yamamura; Akira Kurita; Kuniyoshi Arai
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

  7 in total
  5 in total

Review 1.  Chemotherapy-Induced Sarcopenia.

Authors:  Federico Bozzetti
Journal:  Curr Treat Options Oncol       Date:  2020-01-30

2.  GNRI And Conut Scores: Simple Predictors of Sarcopenia in Metastatic Colorectal Cancer Patients.

Authors:  Zeynep Gülsüm Güç; Canan Altay; Hakan Abdullah Özgül; Hülya Ellidokuz; Tuğba Yavuzşen
Journal:  Support Care Cancer       Date:  2022-06-18       Impact factor: 3.359

3.  Nutritional issues in patients with cancer.

Authors:  Duk Hwan Kim
Journal:  Intest Res       Date:  2019-10-14

Review 4.  Sarcopenia, Malnutrition, and Cachexia: Adapting Definitions and Terminology of Nutritional Disorders in Older People with Cancer.

Authors:  Delky Meza-Valderrama; Ester Marco; Vanesa Dávalos-Yerovi; Maria Dolors Muns; Marta Tejero-Sánchez; Esther Duarte; Dolores Sánchez-Rodríguez
Journal:  Nutrients       Date:  2021-02-26       Impact factor: 5.717

5.  Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer.

Authors:  Masatsugu Amitani; Takaaki Oba; Nami Kiyosawa; Hiroki Morikawa; Tatsunori Chino; Ai Soma; Tadafumi Shimizu; Koichi Ohno; Mayu Ono; Tokiko Ito; Toshiharu Kanai; Kazuma Maeno; Ken-Ichi Ito
Journal:  BMC Cancer       Date:  2022-03-26       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.